Synthesis and evaluation of di‐heterocyclic benzazole compounds as potential antibacterial and anti‐biofilm agents against Staphylococcus aureus
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.14601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Mine Buga Aktekin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mersin University, Mersin, Turkey. Hauptthemen laut MEDLINE: Biofilms, Staphylococcus aureus, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mersin University, Mersin Üniversitesi.
Abstract (Originalsprache)
Cumulative escalation in antibiotic‐resistant pathogens necessitates the quest for novel antimicrobial agents, as current options continue to diminish bacterial resistance. Herein, we report the synthesis of di‐heterocyclic benzazole structures ( 12–19 ) and their in vitro evaluation for some biological activities. Compounds 16 and 17 demonstrated potent antibacterial activity (MIC = 7.81 μg/mL) against Staphylococcus aureus , along with significant anti‐biofilm activity. Noteworthy is the capability of Compound 17 to inhibit biofilm formation by at least 50% at sub‐MIC (3.90 μg/mL) concentration. Furthermore, both compounds exhibited the potential to inhibit preformed biofilm by at least 50% at the MIC concentration (7.81 μg/mL). Additionally, Compounds 16 and 17 were examined for cytotoxic effects in HFF‐1 cells, using the MTT method, and screened for binding interactions within the active site of S. aureus DNA gyrase using in silico molecular docking technique, employing AutoDock 4.2.6 and Schrödinger Glidse programs. Overall, our findings highlight Compounds 16 and 17 as promising scaffolds warranting further optimization for the development of effective antibacterial and anti‐biofilm agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
- Department of Pharmacy Services, Vocational School of Health Services, Tarsus University, Mersin, Turkey.
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
- Department of Analytical Chemistry, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, Turkey.
- Department of Biology, Faculty of Science and Literature, Çukurova University, Adana, Turkey.
- Department of Biology, Faculty of Arts and Sciences, Erzincan Binali Yıldırım University, Erzincan, Turkey.
ORCID-Profile: Oztekin Algul
Förderung
- Mersin University
- Mersin Üniversitesi
Zitieren
APA
Aktekin, M. B., Oksuz, Z., Turkmenoglu, B., Istifli, E. S., Kuzucu, M., & Algul, O. (2024). Synthesis and evaluation of di‐heterocyclic benzazole compounds as potential antibacterial and anti‐biofilm agents against Staphylococcus aureus. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14601
Vancouver
Aktekin MB, Oksuz Z, Turkmenoglu B, Istifli ES, Kuzucu M, Algul O. Synthesis and evaluation of di‐heterocyclic benzazole compounds as potential antibacterial and anti‐biofilm agents against Staphylococcus aureus. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14601
BibTeX
@article{Aktekin2024,
author = {Aktekin, Mine Buga and Oksuz, Zehra and Turkmenoglu, Burcin and Istifli, Erman Salih and Kuzucu, Mehmet and Algul, Oztekin},
title = {Synthesis and evaluation of di‐heterocyclic benzazole compounds as potential antibacterial and anti‐biofilm agents against Staphylococcus aureus},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.14601}
}
EUVIMED